In the fourth episode of Scenius Studio's mini-series "The Use-Case", I sit down with Tuan Cao (@tuan_lifeai), Co-Founder of @LifeNetwork_AI. Tuan and his team started by building a Web2 alternative to 23andMe focused on the Asian genome, but with a key difference…they gave users full control over their data. That was just the beginning of a long-road to build one of the blockchain industry’s leading decentralized science projects. Long before “DeSci” was even a term, LifeAI has been building a decentralized foundation for genetics-based medicine and research. Today, Life has established itself as a base layer protocol that traditional healthcare players are building on top of cheaply and quickly. The future of genetics based personalized treatments might have crypto under the hood. In this episode we discuss: ➔ Why Tuan and team built a 23&Me competitor ➔ Building a web2 genetics business and converting it into a blockchain-based protocol ➔ Defining Decentralized Science (DeSci) and the different sections within the category ➔ What applications are being built on top of the Life protocol ➔ How the Life team enables privacy and data ownership using GeneNFTs ➔ Cost savings and operational efficiencies gained from building your medical home base on-chain Hope you enjoy this episode of Scenius Studio's "The Use-Case". Link to listen below and in bio.